Stay updated on ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Sign up to get notified when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No substantive changes to study details were observed; the updates appear to be minor UI adjustments, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-02T00:27:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    5%
    Check dated 2025-10-04T04:20:05.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.
    Difference
    0.1%
    Check dated 2025-09-27T02:17:13.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' link was removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-12T17:24:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-05T14:00:41.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new chemical compounds related to eptinezumab, while several previous terms and classifications have been removed.
    Difference
    3%
    Check dated 2025-08-29T08:37:46.000Z thumbnail image

Stay in the know with updates to ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.